Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca AbfiledCriticalAstrazeneca Ab
Priority to CU20100206ApriorityCriticalpatent/CU20100206A7/en
Publication of CU20100206A7publicationCriticalpatent/CU20100206A7/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Un compuesto de fórmula (I): ESPACIO PARA LA FÓRMULA y sales farmacéuticamente aceptables de este donde los grupos variables se definen en el interior; y también se describen su uso en la inhibición de 11BETAHSD1, procedimientos para prepararlos y composiciones farmacéuticas que los comprenden.A compound of formula (I): SPACE FOR THE FORMULA and pharmaceutically acceptable salts thereof where the variable groups are defined inside; and its use in the inhibition of 11BETAHSD1, methods for preparing them and pharmaceutical compositions comprising them are also described.
Compounds derived from fumarate; pharmaceutical composition comprising them; and its use in the treatment of an inflammatory or neurodegenerative disease.